HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinibY. Wang, Fred R. Hirsch, Tao Jiang et al.|Annals of Oncology|2018Cited by 217
Counteracting Roles of AMP Deaminase and AMP Kinase in the Development of Fatty LiverMiguel A. Lanaspa, Richard J. Johnson, Carlos A. Roncal-Jiménez et al.|PLoS ONE|2012Cited by 193